Form 8-K - Current report:
SEC Accession No. 0001564590-20-042714
Filing Date
2020-09-08
Accepted
2020-09-08 07:35:37
Documents
12
Period of Report
2020-09-01
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K arwr-8k_20200901.htm   iXBRL 8-K 32815
  Complete submission text file 0001564590-20-042714.txt   161817

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA arwr-20200901.xsd EX-101.SCH 5812
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE arwr-20200901_lab.xml EX-101.LAB 19478
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE arwr-20200901_pre.xml EX-101.PRE 11657
5 EXTRACTED XBRL INSTANCE DOCUMENT arwr-8k_20200901_htm.xml XML 3565
Mailing Address 177 E COLORADO BLVD SUITE 700 PASADENA CA 91105
Business Address 177 E COLORADO BLVD SUITE 700 PASADENA CA 91105 626-696-4702
ARROWHEAD PHARMACEUTICALS, INC. (Filer) CIK: 0000879407 (see all company filings)

EIN.: 460408024 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 001-38042 | Film No.: 201162960
SIC: 2834 Pharmaceutical Preparations